Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia

European Journal of Haematology

Volumn 76, Issue 3, 2006, Pages 230-236

  Tsirigotis, Panagiotis ^a   Pappa, Vassiliki ^a   Labropoulos, Stefanos ^a   Papageorgiou, Sotirios ^a   Kontsioti, Frinda ^a   Dervenoulas, John ^a   Papageorgiou, Efstathios ^a   Panani, Anna ^a   Mantzios, George ^a   Economopoulos, Theofanis ^a   Raptis, Sotirios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Chronic lymphocytic leukemia; Deletion; Methylation specific polymerase chain reaction; Mutation; p16 INK4A gene; Promoter methylation

Indexed keywords

PROTEIN P16INK4A; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EXON; FEMALE; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HOMOZYGOSITY; HUMAN; MALE; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EXONS; GENE DELETION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MUTATION; MUTATION, MISSENSE;

EID: 33645057939     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00604.x     Document Type: Article

References (44)

1. H amblin TJ D avis Z G ardiner A O scier DG S tevenson FK Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocytic leukaemia Blood 1999 94 1848 1854
2. T sihlias J K apusta L S lingerland J The prognostic significance of altered cyclin dependent kinase inhibitors in human cancer Ann Rev Med 1999 50 401 423
3. K amb A G ruis NA W eaver -F eldhaus I L iu Q H arshman K T avtigian SV S tockert E D ay RS IIIrd. J ohnson BE S kolnick MH A cell cycle regulator potentially involved in genesis of many tumor types Science 1994 264 436 440
4. N obori T M iura K W u DJ L ois A T akabayashi K C arson DA Deletions of the cyclin dependent kinase-4 inhibitor gene in multiple cancers Nature 1994 368 753 756
5. H irama T K oeffler P Role of the cyclin-dependent kinase inhibitors in the development of cancer Blood 1995 86 841 854
6. C aldas C H ahn SA D a -C osta LT R edston MS S chutte M S eymour AB W einstein CL H ruban RH Y eo CJ K ern SE Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 1994 8 27 32
7. D reyling MH B ohlander SK A deyanju MO O lopade OI Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridisation Cancer Res 1995 55 984 988
8. C heng JQ J hanwar SC K lein WM B ell DW L ee WC A ltomare DA N obori T O lopade OI B uckler AJ T esta JR p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma Cancer Res 1994 54 5547 5551
9. D e V os S M iller CW T akeuchi S G ombart AF C ho SK K oeffler HP Alterations of CDKN2 (p16) in non-small-cell lung cancer Genes Chromosom Cancer 1995 14 164 170
10. F itz -G erald MG H arkin DP S ilva -A rrieta S et al. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population Proc Natl Acad Sci 1996 93 8541 8545
11. D rexler HG Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukaemia-lymphoma cells Leukemia 1998 12 845 859
12. H ebert J C ayuela JM B erkeley J S igaux F Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias Blood 1994 84 4038 4044
13. S anchez -B eato M S anchez -A guilera A P iris MA Cell cycle deregulation in B-cell lymphomas Blood 2003 101 1220 1235
14. B atova A D icciani MB V u T Y u JC B ridgeman L Y u AL Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia Cancer Res 1997 57 832 836
15. C ohen PL J ames CD K urtin PJ p16 gene alterations in mantle cell lymphoma Blood 1997 90 491a
16. H erman JG C ivin CI I ssa JPJ C ollector MI S harkis SJ B aylin SB Distinct patterns of inactivation of p15INK4B and p16INK4A characterize major types of hematological malignancies Cancer Res 1997 57 837 841
17. N g MHL C hung YF L o KW W ickham NWR L ee JCK H uang DP Frequent hypermethylation of p16 and p15 genes in multiple myeloma Blood 1997 89 2500 2506
18. INK4A gene in multiple myeloma Blood 1997 90 244a
19. M artel V G uerci A H umbert JC G regoire MJ C hery M L ederlin P J onveaux P De novo methylation of tumor suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukemia Br J Hematol 1997 99 320 324
20. B aur AS S haw BP B urri N D elacretaz F B osman FT C haubert P Frequent methylation silencing of p15 INK4a and p16 INK4b in B-cell and T-cell Lymphomas Blood 1999 94 1773 1781
21. M atutes E O wusu -A nkomah K M orilla R G arcia M arco J H oulihan A Q ue TH C atovsky D The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL Leukemia 1994 8 1640 1645
22. S ambrook J F ritch EF M aniatis T Molecular Cloning: A Laboratory Manual
23. B osch F J ares P C ampo E L opez -G uillermo A P iris MA V illamor N T assies D J affe ES M ontserrat E R ozman C Prad-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma Blood 1994 84 2726 2732
24. O rita M S uzuki Y S ekiya T H ayashi K Rapid and sensitive detection of point mutation and polymorphisms using polymerase chain reaction Genomics 1989 5 874 879
25. waf1 genes are associated with aggressive variants of mantle cell lymphomas Blood 1997 89 272 280
26. H erman JG G raff JR M yohanen S N elkin BD B aylin SB Methylation. Specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 1996 93 9821 9826
27. W einberg RA Tumor suppressor gene Science 1991 254 1138 1146
28. H ollstein M S idransky D V ogelstein B H arris CC p53 mutations in human cancers Science 1991 253 49 53
29. K nudson JAG Hereditary cancer, oncogenes, and antioncogenes Cancer Res 1985 45 1437 1443
30. Q uon KC B erns A Haplo-insufficiency? Let me count the ways Genes Dev 2001 15 2915 2921
31. F ero ML R andel E G urley KE R oberts JM K emp CJ The murine gene p27Kip1 is haplo-insufficient for tumor-suppression Nature 1998 396 177 180
32. S tranks G H eight SE M itchell P J adayel D Y uille MAR D e Lord C C lutterbuck RD T releaven JG P owles RL N acheva E Deletions and rearrangement of CDKN2 in lymphoid malignancy Blood 1995 85 893 901
33. G arcia -S anz R G onzalez M V argas M C hillon MC B alanzategui A B arbon M F lores MT S an Miguel JF Deletions and rearrangements of cyclin-dependent kinase 4 inhibitor gene p16 are associated with poor prognosis in B cell non-Hodgkin's lymphomas Leukemia 1997 11 1915 1920
34. INK4B/MTS2 in Human Leukemias and Lymphomas Cancer Res 1995 55 1436 1440
35. INK4B gene deletions in primary leukemias Blood 1995 86 311 315
36. ink4A) gene in primary B-Cell lymphomas Blood 1995 86 2724 2731
37. INK4A gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas Blood 1998 91 2977 2984
38. C aligaris -C appio F Biology of chronic lymphocytic leukemia Rev Clin Exp Hematol 2000 4 5 21
39. H erman JG B aylin SB Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 2003 349 2042 2054
40. G uillerm G G yan E W olowiec D F acon T A vet -L oiseau H K uliczkowski K B auters F F enaux P Q uesnel B p16 (INK4a) and p15 (INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance Blood 2001 98 244 246
41. E steller M C orn PG B aylin SB H erman JG A gene hypermethylation profile of human cancer Cancer Res 2001 61 3225 3229
42. W ong IH N g MH H uang DP L ee JC Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications Blood 2000 95 1942 1949
43. M artinez -D elgado B F ernandez -P iqueras J G arcia MJ A rranz E G allego J R ivas C R obeldo M B enitez J Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin lymphoma Leukemia 1997 11 425 428
44. D askalakis M N guyen TT N guyen C G uldberg P K ohler G W ijermans P J ones PA L ubbert M Demethylation of a hypermethylated p15/INK4B gene in patients with myelodysplastic syndromes by 5-Aza-2′-deoxycytidine (decitabine) treatment Blood 2002 100 2957 2964